Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Consensus Target Price of $100.00 According to Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned an average recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $100.00.

Several analysts have commented on the stock. Weiss Ratings raised shares of Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, October 12th. JPMorgan Chase & Co. raised their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Zacks Research lowered shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 19th. Needham & Company LLC reaffirmed a “buy” rating and issued a $101.00 price objective on shares of Merit Medical Systems in a research note on Tuesday, September 29th. Finally, Canaccord Genuity Group upped their price objective on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a report on Friday, July 31st.

Institutional Trading of Merit Medical Systems

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Brucke Financial Inc. boosted its stake in shares of Merit Medical Systems by 5.8% during the 3rd quarter. Brucke Financial Inc. now owns 4,475 shares of the medical instruments supplier’s stock worth $386,000 after acquiring an additional 247 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Merit Medical Systems by 11.4% during the 3rd quarter. Signaturefd LLC now owns 2,465 shares of the medical instruments supplier’s stock valued at $213,000 after acquiring an additional 253 shares during the last quarter. Sowell Financial Services LLC raised its stake in shares of Merit Medical Systems by 4.0% in the 3rd quarter. Sowell Financial Services LLC now owns 4,609 shares of the medical instruments supplier’s stock valued at $397,000 after acquiring an additional 179 shares in the last quarter. Gibbs Wealth Management raised its stake in shares of Merit Medical Systems by 9.0% in the 3rd quarter. Gibbs Wealth Management now owns 13,926 shares of the medical instruments supplier’s stock valued at $1,201,000 after acquiring an additional 1,145 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC bought a new position in shares of Merit Medical Systems in the 3rd quarter valued at approximately $206,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Down 0.7%

Shares of Merit Medical Systems stock opened at $93.30 on Thursday. The firm has a market cap of $5.57 billion, a price-to-earnings ratio of 38.55, a P/E/G ratio of 2.33 and a beta of 0.51. The stock has a 50-day simple moving average of $88.43 and a 200-day simple moving average of $76.80. Merit Medical Systems has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The firm’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, equities research analysts expect that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.